CARUBBI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.282
EU - Europa 6.853
AS - Asia 6.096
SA - Sud America 818
Continente sconosciuto - Info sul continente non disponibili 148
AF - Africa 131
OC - Oceania 58
Totale 27.386
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.984
SE - Svezia 2.164
SG - Singapore 1.904
CN - Cina 1.626
GB - Regno Unito 1.608
IT - Italia 1.176
HK - Hong Kong 833
BR - Brasile 620
VN - Vietnam 497
DE - Germania 473
FI - Finlandia 398
BD - Bangladesh 305
FR - Francia 224
RU - Federazione Russa 214
TR - Turchia 210
UA - Ucraina 195
KR - Corea 181
CA - Canada 151
IN - India 118
ID - Indonesia 89
BG - Bulgaria 85
AR - Argentina 79
NL - Olanda 69
MX - Messico 62
AU - Australia 55
IQ - Iraq 47
JP - Giappone 34
ZA - Sudafrica 33
EC - Ecuador 31
IE - Irlanda 29
MY - Malesia 29
EG - Egitto 27
PL - Polonia 27
RO - Romania 26
VE - Venezuela 26
AE - Emirati Arabi Uniti 24
ES - Italia 23
AT - Austria 22
BE - Belgio 22
PK - Pakistan 22
CO - Colombia 21
PH - Filippine 20
SA - Arabia Saudita 20
LT - Lituania 19
CR - Costa Rica 18
CL - Cile 17
UZ - Uzbekistan 17
DK - Danimarca 15
IR - Iran 15
IL - Israele 14
MA - Marocco 14
TN - Tunisia 14
HN - Honduras 13
JO - Giordania 13
TH - Thailandia 12
CZ - Repubblica Ceca 11
QA - Qatar 11
KE - Kenya 10
NP - Nepal 10
AZ - Azerbaigian 9
CH - Svizzera 9
DO - Repubblica Dominicana 8
NI - Nicaragua 8
PE - Perù 8
GR - Grecia 7
JM - Giamaica 7
TW - Taiwan 7
MK - Macedonia 6
PY - Paraguay 6
RS - Serbia 6
UY - Uruguay 6
DZ - Algeria 5
GT - Guatemala 5
LB - Libano 5
PA - Panama 5
SI - Slovenia 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AO - Angola 4
BF - Burkina Faso 4
ET - Etiopia 4
EU - Europa 4
KG - Kirghizistan 4
OM - Oman 4
PT - Portogallo 4
AL - Albania 3
BO - Bolivia 3
BY - Bielorussia 3
BZ - Belize 3
KZ - Kazakistan 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
CI - Costa d'Avorio 2
CY - Cipro 2
GE - Georgia 2
NG - Nigeria 2
Totale 27.213
Salva come PNG Salva come JPEG
Città #
Ashburn 1.836
Stockholm 1.785
Singapore 1.290
Santa Clara 1.169
Southend 1.062
Fairfield 889
San Jose 823
Hong Kong 808
Chandler 659
Woodbridge 643
Hefei 599
Council Bluffs 462
Houston 458
Jacksonville 395
Seattle 353
Wilmington 337
Cambridge 321
Helsinki 313
Dearborn 297
Beijing 277
Ann Arbor 255
London 255
Nyköping 243
Los Angeles 207
Seoul 178
Cincinnati 172
New York 161
Ho Chi Minh City 154
Modena 133
Hanoi 121
Milan 118
The Dalles 117
Izmir 112
San Diego 106
Chicago 99
Princeton 93
Bremen 83
São Paulo 83
Sofia 82
Lauterbourg 80
Buffalo 78
Eugene 70
Dallas 67
Jakarta 66
Moscow 65
Grafing 61
Des Moines 58
Boardman 56
Shanghai 53
Munich 52
Rome 51
Columbus 49
Orem 47
Phoenix 43
Melbourne 42
Falls Church 41
Bologna 39
Reggio Emilia 38
Toronto 37
Montreal 36
Salt Lake City 35
Brooklyn 31
Nuremberg 30
Frankfurt am Main 29
Kent 29
Parma 28
Atlanta 27
Naples 27
Washington 27
Haiphong 26
Tokyo 26
Dublin 25
Denver 24
Amsterdam 23
Guangzhou 22
North Bergen 22
Da Nang 21
Elk Grove Village 20
San Francisco 20
Brussels 19
Chennai 19
Johannesburg 19
Nanjing 19
Redwood City 19
Mexico City 18
Ottawa 18
Warsaw 18
Charlotte 17
Manchester 17
Mumbai 17
Philadelphia 17
Baghdad 16
Miano 16
Rio de Janeiro 16
San José 16
Tampa 16
Palermo 15
Timisoara 15
Belo Horizonte 14
Boston 14
Totale 19.524
Salva come PNG Salva come JPEG
Nome #
"Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man". 2.063
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 545
A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease 507
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 448
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease 433
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene 402
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 392
Effectiveness of dietetic counselling in lowering plasma cholesterol of children affected by hypercholesterolemia 380
Management of bone disease in Gaucher disease type 1: clinical practice 377
Effects of bariatric and metabolic surgical procedures on dyslipidemia: a retrospective, observational analysis. 375
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 374
Nutrition in adult patients with selected lysosomal storage diseases 371
The association of Mediterranean diet and exercise modifications with anthropometric parameters in a psychiatric community population: A pilot study 362
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 362
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 361
Growth of human herpesvirus 6 in HepG2 cells 351
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes 350
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 346
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 337
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 333
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 333
Anatomia e fisiologia delle vie biliari 329
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 326
The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher disease 320
Cholesterol esterase activity of human intestinal mucosa 318
Review article: effect of bile salt pool composition on hepatic and biliary functions 315
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 310
Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins 307
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy 299
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 299
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 294
Bile acid structure and regulation of biliary protein secretion and composition in man 292
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 287
Global multi-stakeholder endorsement of the MAFLD definition 282
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 280
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years 280
Fabry disease: raising awareness of the disease among physicians 277
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 275
Association of nonalcoholic fatty liver disease (Nafld) with peripheral diabetic polyneuropathy: A systematic review and meta-analysis 275
Nonalcoholic fatty liver disease induced by leuprorelin acetate 274
"Bile acid synthesis: metabolism of 3B-OH-5-cholenoic acid to chenodeoxycholic acid" 268
Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease 265
Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease 264
Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy 263
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 262
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study 260
Minimal disease activity in Gaucher disease: criteria for definition 258
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 257
Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis 256
Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study 243
A case of statin-induced liver injury with positive rechallenge with a second statin. Is there a class effect? 242
Bile acid and hepatocyte death 240
Effect of aging on cholesterol 7 alpha-hydroxylation in humans 238
Erratum to: Management of Bone Disease in Gaucher Disease Type 1: Clinical Practice 233
Patogenesi della colelitiasi 232
Gaucher Disease in Bone: From Pathophysiology to Practice 232
Cholesterol esterase activity of human intestinal mucosa 226
Cholesterol Esterase Activity of human intestinal mucosa 225
Parkinson's disease in Gaucher disease patients: What's changing in the counseling and management of patients and their relatives? 218
Malattie delle vie biliari 216
Prevalence rates of gallstone disease in Italy: the Chianciano population study 216
EFFECT OF CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID ADMINISTRATION ON ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN LIVER 216
Inquadramento delle sindromi colestatiche. 215
Regulation of bile acid synthesis in humans: studies on cholesterol 7alpha-hydroxylation 'in vivo' 215
Hyperferritinemia and diagnosis of type 1 Gaucher disease 214
Rupture d'un anevrysme de l'aorte infecté par salmonelle. 211
Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus 209
MECCANISMI DI CITOTOSSICITÀ DEGLI ACIDI BILIARI. 207
Liver metastases from carcinoid tumor: Imaging patterns 207
Cholesterol esterase activity in the small bowel of humans 204
Nuove prospettive terapeutiche con acidi biliari. 202
Regulation of bile acid synthesis in humans 201
Regulation of cholesterol absorption in humans 198
Effects of bile acid pool composition on hepatic metabolism of cholesterol in man 198
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 196
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist 195
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. 194
Quality of life in adult patients with glycogen storage disease type i: Results of a multicenter Italian study 194
Incidence of colorectal cancer and polyps in a health care district: experience at 1 year of registration 183
LA SECREZIONE LIPIDICA BILIARE 180
Deoxycholic acid (DCA) feeding induces significant changes of biliary lipid composition in cirrhotic patients 179
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 174
Dislipidemie.In Teodori 2004. Trattato italiano di medicina interna 170
Effect of feeding small doses of deoxycholic acid on bile lipid composition in patients with liver cirrhosis 165
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 165
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 162
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 162
Pancreatic cholesterol esterase of intestinal mucosa: characterization of enzymatic activity in humans 161
Effect of Chenodeoxycholic acid and Ursodeoxycholic acid administration on acyl-CoA: cholesterol acyl tranferase activity in human liver. 156
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study 155
Fattori di rischio della litiasi biliare: importanza dell'alimentazione 152
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 149
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 146
Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis 136
Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: A sub-study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry 126
Towards needed improvements in inherited metabolic medicine in adulthood: The SIMMESN adult metabolic working group and MetabERN Joint Position Statement 123
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease 123
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 123
Long-term outcome of a cohort of Italian patients affected with alpha-Mannosidosis 118
How to overcome barriers to the implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy 114
Totale 27.353
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.348 0 0 0 121 94 148 71 64 196 126 370 158
2022/20231.755 164 165 126 188 244 293 34 168 190 29 85 69
2023/20241.042 37 62 59 86 232 93 101 137 22 56 51 106
2024/20254.140 134 54 61 279 750 581 343 211 353 205 543 626
2025/20269.738 484 339 643 781 1.062 597 1.140 346 2.548 775 567 456
2026/20272.673 252 519 698 1.204 0 0 0 0 0 0 0 0
Totale 27.386